[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Blakely et al., 1984 - Google Patents

Heavy-ion radiobiology: Cellular studies

Blakely et al., 1984

View PDF
Document ID
5595451726770455888
Author
Blakely E
Ngo F
Curtis S
Tobias C
Publication year
Publication venue
Advances in radiation biology

External Links

Snippet

Publisher Summary This chapter focuses on heavy-ion tissue radiobiology. It also discusses cell transformation effects resulting from heavy ions and the dose response of various in vitro mammalian cell lines to high-energy carbon, neon, silicon, and argon beams under aerobic …
Continue reading at escholarship.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1087—Ions; Protons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/109—Neutrons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems
    • A61N5/1031—Treatment planning systems using a specific method of dose optimization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1077—Beam delivery systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations

Similar Documents

Publication Publication Date Title
Blakely et al. Heavy-ion radiobiology: Cellular studies
Kraft Tumor therapy with heavy charged particles
Weber et al. Comparison of carbon ions versus protons
Raju Heavy particle radiotherapy
Urano et al. Relative biological effectiveness of a high energy modulated proton beam using a spontaneous murine tumor in vivo
Joiner et al. Linear energy transfer and relative biological effectiveness
Blakely et al. Biology of charged particles
Joiner et al. The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses
McNally Cell survival
Jones Practical radiobiology for proton therapy planning
Kiger et al. Functional and histological changes in rat lung after boron neutron capture therapy
Pizzarello et al. Radiation biology
Kraft Radiobiological effects of highly charged ions
Tilikidis et al. Microdosimetric description of beam quality and biological effectiveness in radiation therapy
Ainsworth et al. Response of colony-forming units-spleen to heavy charged particles
Howell et al. Neutron capture enhances dose and reduces cancer cell viability in and out of beam during helium and carbon ion therapy
Yasui et al. Gadolinium neutron capture in glioblastoma multiforme cells
Korcyl Track structure modelling for ion radiotherapy
Bertsche et al. Modifications in repair and expression of potentially lethal damage (α-PLD) as measured by delayed plating or treatment with β-araA in plateau-phase Ehrlich ascites tumor cells after exposure to charged particles of various specific energies
Kal Responses of a rat rhabdomyosarcoma and rat skin to irradiation with gamma rays and 15 MeV neutrons at low dose rates
Afzal et al. Radioprotection of mouse colony forming units-spleen against heavy-charged particle damage by WR 2721
Torrisi et al. Nuclear reactions for protontherapy intensification
Maruyama et al. RBE of spleen CFU-S to low dose rate Cf-252 or photon radiation in vivo
Kraft Radiobiological Effects of Highly Charged Ions: Their relevance for tumor therapy and radioprotection in space
Masunaga et al. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction